This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment

Authoring team

Current preferred treatment for clubfoot is the Ponseti method (1) - is a detailed method of manipulation and casting without major surgical releases

  • treatment preferences is via a primarily a non-operative approach through the Ponseti method
    • method has become the standard of care and completely eliminates the need for extensive operative correction in over 98% of patients if applied correctly
    • treatment involves manipulation, a series of castings, percutaneous Achilles tenotomy and foot bracing (2)
    • a precise sequence of manipulations of the clubfoot that lead to correction of the deformity
      • Ponseti stressed that the cavus should be corrected by raising the first metatarsal, which initially makes the deformity look 'worse,' and that correction should occur around the head of the talus without the heel being touched. At weekly intervals the foot is manipulated into the maximum position of correction and then held in a plaster of Paris cast.
    • with correct application of the procedure and appropriate patient adherence, complete correction can be achieved in as little as 16 days with an accelerated casting protocol

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.